| 2024/04/18 12:23:19 | |
|---|---|
| Price | |
| 145.30 EUR | |
| Difference | -4.12% (-6.25) |
General attributes
| ISIN | DE0006599905 |
| Symbol | MRK |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 19,024 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 146.20 EUR (100) |
| Ask (Ask size) | 147.30 EUR (100) |
| Open | 146.90 EUR |
| High | 146.90 EUR |
| Low | 145.30 EUR |
| Close (prev. day) | 151.55 EUR |
| VWAP | 145.30 EUR |
| Volume (pcs) | 20 |
| Trading volume | 2,906.00 |
| Number of trades | 2 |
| Last size | 20 |
Futures and Options
| Related Futures | 38 |
| Related Options | - |
PDF Downloads
| Company report: MERCK KGAA |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/18 12:23:19 | |
|---|---|
| Price | |
| 145.30 EUR | |
| Difference | -4.12% (-6.25) |
General attributes
| ISIN | DE0006599905 |
| Symbol | MRK |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 19,024 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 146.20 EUR (100) |
| Ask (Ask size) | 147.30 EUR (100) |
| Open | 146.90 EUR |
| High | 146.90 EUR |
| Low | 145.30 EUR |
| Close (prev. day) | 151.55 EUR |
| VWAP | 145.30 EUR |
| Volume (pcs) | 20 |
| Trading volume | 2,906.00 |
| Number of trades | 2 |
| Last size | 20 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +1.88% | -8.46% | +1.75% |
| Perf (abs.) | +2.80 | -14.00 | +2.60 |
| Beta | 0.52 | 0.70 | 0.72 |
| Volatility | 30.73 | 26.20 | 28.90 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 151.91 EUR (3) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 156.91 EUR (23) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 151.60 EUR (65) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 155.26 EUR (44) |
| YTD High | date | 163.60 EUR (2024/03/28) |
| YTD Low | date | 141.20 EUR (2024/01/08) |
| 52 Weeks High | date | 170.00 EUR (2023/06/07) |
| 52 Weeks Low | date | 135.80 EUR (2023/12/13) |
All listings for MERCK KGAA
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/04/18 | 17:36 | 146.75 EUR | 74.39 | 7,410 |
| Vienna Stock Exchange | 2024/04/18 | 17:32 | 146.50 EUR | 0.00 | 2 |
| Tradegate | 2024/04/18 | 17:24 | 146.50 EUR | 2.25 | 229 |
| Stuttgart | 2024/04/18 | 17:35 | 146.30 EUR | 0.22 | 127 |
| SIX Swiss Exchange | 2020/04/01 | 17:35 | 94.40 EUR | 0.00 | 1 |
| SIX Swiss Exchange | 2022/11/02 | 17:36 | 223.00 CHF | 0.00 | 1 |
| Munich | 2024/04/18 | 12:23 | 145.30 EUR | 0.00 | 2 |
| London Stock Exchange European Trade Reporting | 2024/04/18 | 17:30 | 146.275 EUR | 0.00 | 2 |
| Hanover | 2024/04/18 | 14:37 | 145.25 EUR | 0.00 | 2 |
| Hamburg | 2024/04/18 | 08:16 | 144.20 EUR | 0.00 | 1 |
| Frankfurt | 2024/04/18 | 14:55 | 144.25 EUR | 0.13 | 8 |
| FINRA other OTC Issues | 2024/04/17 | 21:54 | 158.75 USD | 0.05 | 5 |
| Euronext Milan MTF Trading After Hours | 2024/04/17 | 17:44 | 147.20 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/04/18 | 15:49 | 146.10 EUR | 0.00 | 4 |
| Duesseldorf | 2024/04/18 | 16:32 | 146.65 EUR | 0.00 | 5 |
| Berlin | 2024/04/18 | 08:02 | 145.85 EUR | 0.00 | 1 |
Company Logo
Contact Details
| MERCK KGAA |
| - - |
| Frankfurter Strasse 250 - 64293 Darmstadt |
| Telefon: +49-6151-72-0 |
| Fax: +49-6151-72-5577 |
| E-mail: - |
PDF Downloads
| Company report: MERCK KGAA | |
Company Profile
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany. |
Members of Management Board
| Kai Beckmann | Member of Executive Committee |
| Matthias Heinzel | Member of Executive Committee |
| Belén Garijo López | Member of Executive Committee |
| Helene von Roeder | Member of Executive Committee |
| Peter Guenter | Member of Executive Committee |
Board of directors
| Michael Kleinemeier | Chairman of Supervisory Board |
| Alexander Putz | Member of Supervisory Board |
| Christian Raabe | Member of Supervisory Board |
| Daniel Thelen | Member of Supervisory Board |
| Dietmar Oeter | Member of Supervisory Board |
| Gabriele Eismann | Member of Supervisory Board |
| Helga Rübsamen-Schaeff | Member of Supervisory Board |
| Simon Thelen | Member of Supervisory Board |
| Anne Lange | Member of Supervisory Board |
| Barbara Lambert | Member of Supervisory Board |
| Birgit Biermann | Member of Supervisory Board |
| Jürgen Glaser | Member of Supervisory Board |
| Peter Emanuel Merck | Member of Supervisory Board |
| Renate Koehler | Member of Supervisory Board |
| Sascha Held | Member of Supervisory Board |